Development of a novel class of tubulin inhibitors with promising anticancer activities.
Xi J, Zhu X, Feng Y, Huang N, Luo G, Mao Y, Han X, Tian W, Wang G, Han X, Luo R, Huang Z, An J.
Xi J, et al. Among authors: huang n, huang z.
Mol Cancer Res. 2013 Aug;11(8):856-64. doi: 10.1158/1541-7786.MCR-12-0177. Epub 2013 May 10.
Mol Cancer Res. 2013.
PMID: 23666368
Free article.